Home
Storia in 1 fonti
Cognitive symptoms improve in migraine with eptinezumab
Adults with migraine whose previous preventive therapy had failed saw improvements in cognitive symptoms with 12 months of eptinezumab, according to a poster presented at the American Headache Society 68th Annual Scientific Meeting. Eptinezumab (Vypeti; Lundbeck) targets calcitonin gene-related peptides (CGRPs) to prevent episodic and chronic migraine, according to Richard B. Lipton, MD, Edwin S.
Raccontata da
healio.com
Timeline cronologica
- ·
Monoclonal antibody lowers migraine days in adults with prior preventive treatment failure
In adults with prior preventive migraine treatment failures, an investigational monoclonal antibody led to larger decreases in monthly migraine days vs. placebo, according to a…
- ·
Cognitive symptoms improve in migraine with eptinezumab
Adults with migraine whose previous preventive therapy had failed saw improvements in cognitive symptoms with 12 months of eptinezumab, according to a poster presented at the…